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Abstract | Fluorophores have transformed the way we study biological systems, enabling non-11 
invasive studies in cells and intact organisms, which increase our understanding of complex 12 
processes at the molecular level. Fluorescent amino acids (FlAAs) have become an essential 13 
chemical tool because they can be used to construct fluorescent macromolecules, such as 14 
peptides and proteins, without disrupting their native biomolecular properties. Fluorescent and 15 
fluorogenic amino acids with unique photophysical properties have been designed for tracking 16 
protein–protein interactions in situ or imaging nanoscopic events in real-time with high spatial 17 
resolution. In this Review, we discuss advances in the design and synthesis of FlAAs and how 18 
they have contributed to the field of chemical biology in the past 10 years. Important areas of 19 
research that we review include novel methodologies to synthesize building blocks with 20 
tunable spectral properties, their integration into peptide and protein scaffolds using site-21 
specific genetic encoding and bio-orthogonal approaches, and their application to design novel 22 
artificial proteins as well as to investigate biological processes in cells by means of optical 23 
imaging. 24 
 25 
[H1] Introduction  26 
 27 
 Fluorescence-based techniques have revolutionized our understanding of biological 28 
processes, as they allow researchers to examine the localization, trafficking and activity of 29 
biomolecules in cells, tissues and even whole intact organisms in a non-invasive manner.1-4 30 
Many natural peptides and proteins have key roles in various biological processes; however, 31 
directly visualizing these molecules is hampered by the fact they generally do not exhibit strong 32 
fluorescence emission. Whereas this low ‘background’ fluorescence boosts the sensitivity of 33 
spectroscopy and imaging experiments, its weak levels highlight the need for labelling 34 
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strategies that can facilitate the detection of these macromolecules. Fluorescent labelling of 35 
peptides and proteins has been successfully used in numerous ways, from the widely used 36 
expression of fluorescent protein fusions (such as green fluorescent protein5 (GFP) and 37 
subsequent derivatives6,7) to the fusion of proteins with self-labelling tags (such as SNAP, 38 
CLIP and HALO tags8-10) or modification with specific peptide sequences that can bind to 39 
small molecules with high affinity (such as FlASH and ReASH11,12). All of these approaches 40 
have led to remarkable biological discoveries, but they typically involve a large structural 41 
modification of the peptides or proteins of interest, which can alter their biomolecular 42 
properties.  43 
 Non-natural fluorescent amino acids (FlAAs) have been developed as chemical 44 
alternatives for the derivatization of peptides and proteins in a less disruptive manner. Owing 45 
to their small size and similarity to the natural residues found in polypeptides, they can be used 46 
to fluorescently label macromolecules while retaining their overall function with minimal 47 
perturbation of the native protein structure. The toolbox of FlAAs expanded considerably in 48 
the early 2000s, partly due to the development of numerous FlAAs13 with unique optical 49 
properties, including environmental sensitivity14-16, responsive to metal chelation17, tunable 50 
fluorescence emission and prolonged lifetime18). Importantly, these modular building blocks 51 
can be introduced at specific sites in small peptides using solid-phase peptide synthesis19 52 
(SPPS) or into larger proteins by genetic encoding20 to generate fluorescent, native-like 53 
biomolecules, enabling biological experiments that would be intractable by other means, 54 
including analysis of protein conformational changes, monitoring of protein–protein 55 
interactions and activity studies in live cells. 56 
 Over the past 10 years, a substantial increase in the number of versatile synthetic 57 
strategies (such as multicomponent reactions21, metal-catalysed reactions22, light-induced 58 
transformations23 and bioorthogonal chemistry24) to fine-tune the chemical structure of 59 
fluorophores25 and natural building blocks has accelerated the design and preparation of new 60 
FlAAs. In this Review, we provide an overview of different chemical transformations that have 61 
been used to generate novel building blocks with bespoke fluorescent properties and to 62 
facilitate their site-specific integration into peptides and proteins. We also discuss how the 63 
range of applications of FlAAs has extended to include many biological assays in vitro, in cells 64 
and in vivo, which has been facilitated by a rapid expansion in the use of spectroscopic and 65 
imaging-based techniques. Finally, we review the versatility of FlAAs from the point of view 66 
of an end-user and present several examples of the application of FlAAs in chemical biology, 67 
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including molecular recognition studies, live-cell imaging and applications in synthetic biology 68 
and microbiology (Figure 1).  69 
  70 
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[H1] Synthesis of FlAAs 71 
 72 
[H2] Fluorescent analogues of natural amino acids  73 
 Three canonical amino acids, (tryptophan, tyrosine and phenylalanine, are fluorescent 74 
and thus might have potential as naturally-occurring fluorophores26; however, their optical 75 
properties (such as excitation and emission wavelengths, brightness and photostability) are 76 
suboptimal for most biological assays. Tryptophan, the most commonly used fluorophore 77 
among natural amino acids, absorbs and emits in the ultraviolet range (absorption wavelength 78 
(λabs) = 280 nm; emission wavelength (λem) = 346 nm) and its fluorescence quantum yield is 79 
~20%27.  80 
 Initial attempts to improve the fluorescent properties of tryptophan yielded 81 
azatryptophans as potential isosteric substitutes in proteins28. Although 4-azatryptophans have 82 
a longer emission wavelength (λem.= 425 nm) than tryptophan and a large Stokes shift 83 
(>130 nm), they are typically less bright than tryptophan. Alternative approaches have involved 84 
the preparation of cyanotryptophans, which have improved fluorescence quantum yields 85 
(approaching ~50%29) owing to the incorporation of the strong electron withdrawing cyano 86 
group. Cyanotryptophans can be synthesized from commercially available cyanoindoles, and 87 
the red-shifted emission wavelength of 6-cyanotryptophan (1a) (λem= 370 nm) enabled its use 88 
for Förster resonance energy transfer (FRET) experiments to study protein–DNA interactions. 89 
Subsequent studies identified 4-cyanotryptophan (1b) as an amino acid with improved optical 90 
properties30. A key step in the synthesis of 4-cyanotryptophan is the palladium (Pd)-catalysed 91 
incorporation of the cyano group at position 4 of L-tryptophan. Remarkably, the emission 92 
maximum of 4-cyanotryptophan is in the blue visible region (λem = 405 nm) and it has a high 93 
quantum yield (~80%), good photostability and a long fluorescence lifetime (~13.7 ns), which 94 
makes it an interesting building block for spectroscopic and microscopic measurements of 95 
proteins, such as the study of peptide–membrane interactions31. The structural similarity of 96 
cyanotryptophans to tryptophan also makes them an attractive platform to explore enzyme-97 
based reactions, facilitating the preparation of enantiopure tryptophan analogues by 98 
derivatization at multiple aromatic positions, using, for example, tryptophan synthase S 99 
(TrpS)32 or variants of its β-subunit (TrpB) 33.  100 
 101 
 Extended tryptophan analogues have been also designed by conjugation of homocyclic 102 
and heterocyclic systems to the indole moiety, and include tricyclic tryptophan analogues (2) 103 
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derived from pyrrolo(iso)quinolines34, tryptophan derivatives obtained by hydrogen-mediated 104 
coupling of 1,2,3-triazoles to indoles35 (3a) and a series of 2-arylated tryptophans (3b) obtained 105 
by Pd-mediated C–H functionalization36. Cross-coupling reactions (such as Suzuki–Miyaura 106 
couplings) have also been effective for preparing C4-substituted tryptophans37, although the 107 
effect of these substitutions on the optical properties of tryptophan has not been reported. Of 108 
note, extended tryptophans have a red-shifted emission wavelength (λem.= 420–480 nm)34-36 109 
and some have been incorporated in Escherichia coli dihydrofolate reductase (DHFR) using in 110 
vitro translation, resulting in minimal disruption of DHFR function38 and thus demonstrating 111 
the potential of these molecules for monitoring conformational changes in macromolecular 112 
structures.  113 
 114 
[H2] Non-natural FlAAs  115 
 Despite the remarkable progress in the synthesis of fluorescent analogues of natural 116 
amino acids, numerous non-natural FlAAs with different optical properties have been 117 
developed (Figure 2). The synthetic approaches to generate non-natural FlAAs can be broadly 118 
categorized into those that involve appending fluorescent moieties to amino acids and those 119 
that involve de novo construction of amino acids with integrated chromophores (Figure 2).  120 
[H3] Palladium catalysis. Pd-catalysed reactions are one of the most commonly used 121 
approaches for the synthesis of non-natural FlAAs. Biphenyl derivatives of phenylalanine (4a) 122 
have been prepared by Suzuki coupling of biphenyl boronic acids with iodophenylalanine39,40. 123 
Their emission maximum is red-shifted relative to that of phenylalanine (~340 nm versus 282 124 
nm, respectively) and they have high quantum yields (~70%). Suzuki couplings have also been 125 
used in the synthesis of fluorescent D-amino acids (FDAAs), including 4-acetamidobiphenyl 126 
groups (4b), which have a slightly longer emission wavelength (~380 nm)41. Heck reactions 127 
have been employed to extend the π-conjugation of tyrosine42, yielding styryl-containing 128 
tyrosine analogues (5) with tunable fluorescence quantum yields (from 10% to 90%) and 129 
emission maximathat cover the entire visible spectrum (λem.= 400–800 nm). Sonogashira 130 
coupling reactions have been used to append aryl-containing acetylene derivatives to 131 
benzoxazol-5-yl-alanine to produce FlAAs (6) with a high quantum yield and emission maxima 132 
in ultraviolet and blue wavelengths (λem.= 340–450 nm) 43. Similarly, xanthone structures (λ-133 
em.= 380 nm) have been incorporated into the alanine core by Negishi couplings44 (7a). The 134 
high efficiency of Pd-catalysed couplings (such as the Buchwald–Hartwig reaction) has also 135 
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facilitated the synthetic optimization of widely used non-natural FlAAs, such as acridon-2-136 
ylalanine (ACD) (7b), which is one of the brightest blue-emitting FlAAs reported to date45. 137 
 138 
[H3] C–H activation. C–H activation is another synthetic methodology that has contributed 139 
substantially to the development of non-natural FlAAs, particularly for the construction of new 140 
tryptophan-based amino acids. Trp-BODIPY (8a) was the first BODIPY-containing tryptophan 141 
analogue, which has excellent photophysical properties (λabs.= 500 nm; λem.= 530 nm) and is 142 
compatible with SPPS46. A similar approach was used to prepare Trp(redBODIPY) (8b), which 143 
has a red-shifted maximum excitation and emission wavelength (λabs.= 560 nm, λem.= 144 
590 nm)47, and also was extended for the synthesis of styryl-derivatized tryptophan analogues 145 
by C–H olefination at the C2 position of the indole moiety48. Given that the extension of π-146 
conjugation systems often leads to improved photophysical properties, as described above with 147 
Heck reactions42, this strategy has the potential to yield FlAAs with novel optical properties. 148 
Pd-catalysed sp3 C–H activation has also been used to append green and red-fluorescent 149 
BODIPY dyes to the side chains of alanine and phenylalanine (9) (λem.= 510–625 nm)49 and to 150 
the C2 position of tryptophan by a novel ruthenium(II)-catalysed C–H alkylation50.  151 
[H3] Copper and rhodium catalysis. Further examples of metal-catalysed reactions include 152 
the Ullmann-type reaction for coupling the fluorophore pyrene to the phenol group of tyrosine 153 
(10a) using copper catalysis (λem.= 390 nm; quantum yield ~40%)51, or the widely used copper-154 
catalysed azide–alkyne cycloaddition (CuAAC) to conjugate standard fluorophores, such as 155 
coumarins -(λem.= 380 nm), benzothiadiazoles (λem.= 470 nm), fluorescein (λem.= 510 nm), 156 
dansyl (λem.= 520 nm), nitrobenzodioxazoles (NBDs; λem.= 530 nm), and naphthalimides (λem.= 157 
550 nm), to the side chains of different amino acids52-54 (11). Fluorescent arylalanines (12) 158 
(λem.= 400 nm; quantum yield ~60%) have been synthesized via the formation of C–C bonds 159 
between several polyaromatic hydrocarbons and alanine using rhodium catalysis55. 160 
[H3] Subheading. Conventional reactions involving the formation of amides56-61 (13), 161 
carbamates62 (14) or thioureas57,58,63 (15) have also been explored for modifying the side chains 162 
of different amino acids with various fluorophores. Other reactions include Knoevenagel-like 163 
condensation to derivatize aminodicarboxylate β-ketoesters with pyrene64 (16) or synthesis of 164 
a green-fluorescent FlAA (17) (λem.= 540 nm) by coupling 4-dimethylamino-1-naphthalenes to 165 
methyl (2S)-5-(dimethoxyphosphoryl)-4-oxo-2-(tritylamino)-pentanoate via a Horner–166 
Wadsworth–Emmons reaction65. The simplicity of some reactions and the availability of 167 
properly derivatized fluorescent building blocks has also facilitated the preparation of 168 
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collections of FlAAs. For example, using Michael addition, a small library of D-cysteine FlAAs 169 
(18) with thiol-containing fluorophores was generated66, and maleimide-4-aminophthalimide67 170 
(19) was coupled to L-cysteine. Furthermore, the Fukuyama–Mitsunobu reaction was used to 171 
couple 6-acyl-2-naphthylamine to L-serine to produce 3-(6-acetylnaphthalen-2-ylamino)-2-172 
aminopropanoic acid (ANAP) (20), a building block with remarkable optical properties (λem.= 173 
490 nm, quantum yield ~50%) that is widely used for fluorescent labelling of proteins68. NBD-174 
like fluorophores have been conjugated by a nucleophilic aromatic substitution (SNAr) reaction 175 
to nucleophilic groups (21) in amino acid side chains (such as 3-amino-alanine)58,69, whereas 176 
phospholyl(borane) amino acids (22) have been produced by nucleophilic substitution of 177 
fluorescent phospholide anions with iodo-derivatized amino acids70, which enabled the 178 
synthesis of a range of phospholyl derivatives with fluorescence properties covering a broad 179 
spectrum of emission maxima wavelengths from ultraviolet to green (λem.= 340–530 nm).  180 
[H3] Flavone-based FlAAs. Alternative synthetic approaches have involved the de novo 181 
design of FlAAs by building fluorophores into an amino acid structure (Figure 3). For 182 
example, flavone-based amino acids (23) (Figure 3a) are produced by constructing the 183 
fluorophore 3-hydroxychromone from tyrosine by aldol condensation, followed by oxidative 184 
cyclization (for example, the Algar–Flynn–Oyamada reaction)71-73. Of note, flavone FlAAs 185 
show excited-state intramolecular proton transfer (ESIPT) fluorescence, and they only 186 
minimally perturb the structure of peptides owing to their small size. Another FlAA with a 187 
built-in fluorophore, benzoacridone-modified alanine, was synthesized by an Ullmann-type 188 
coupling between 3-chloro-2-naphthoic acid and aminophenylalanine, followed by cyclization 189 
of 2-aminonapthoic acid to yield green-fluorescent benzoacridone amino acid (λem.= 500–550 190 
nm, quantum yield ~50%)74. Furthermore, a non-natural FlAAs have been synthesised by 191 
building aryl-substituted pyridyl, pyrazole, benzotriazole and pyrazoloquinazoline (24) 192 
heterocyclic chromophores on aspartic acid and asparagine structures (λem.= 348–460 nm)75-78 193 
(Figure 3b).  194 
[H3] Coumarin based FlAAs. The simplicity of the coumarin scaffold (that is, 1-benzopyran-195 
2-one) has facilitated the preparation of FlAAs integrating this fluorescent structure. Coumarin-196 
based FlAAs can be prepared by Pechmann condensation, either between an amino acid 197 
containing a β-ketoester unit and a phenol derivative or between tyrosine and an ethyl 198 
acetoacetate derivative79,80. Alternatively, 7-(hydroxycoumarin-4-yl)ethylglycine is prepared 199 
by Pd-catalysed cross coupling between 2,4-dimethoxyphenylboronic acid and amino acids 200 
containing β-ketoester groups81. The brightness of coumarin-based FlAAs, with quantum 201 
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yields reaching 70%, together with their fairly small size, have made them excellent building 202 
blocks for multiple applications in chemical biology.  203 
 204 
[H1] Bioactive fluorescent peptides  205 
 206 
[H2] Studying biomolecular interactions  207 
 Peptides are excellent scaffolds for biological studies, as they can be used to monitor 208 
highly specific molecular interactions with a broad range of biomolecules. Fluorescent peptides 209 
have traditionally been synthesized by coupling fluorophores to reactive groups (initially to 210 
amines, carboxylic acids and thiols82, but now also to imidazoles83 or phenols84) on the side 211 
chains of amino acids or in conveniently placed spacers. However, in some cases, this synthetic 212 
approach can alter the native conformation  of the peptide or its biological properties (such as 213 
functional activity, binding affinity and/or subcellular localization)85. One synthetic alternative 214 
to minimize the effect of fluorescent labelling is to embed FlAAs within the sequence of the 215 
peptides (to avoid the modification of polar groups, such as amines, carboxylic acids, and 216 
thiols, which may be crucial for its bioactivity) or to optimize suitable spacers86. These 217 
methodologies rely on the chemical robustness and flexibility of SPPS, which enables the 218 
efficient preparation of highly diverse peptides, including those that incorporate non-natural 219 
FlAAs87.  220 
[H3] Monitoring protein–protein and protein–DNA interactions. Most biological 221 
processes rely on the interaction of proteins with their binding partners. In this context, 222 
fluorescent peptides have been developed to better understand protein-based interactions at the 223 
molecular level and to help in the discovery of new drugs to modulate them. For example, 224 
flavone-based solvatochromic FlAAs were incorporated at specific sites in a peptide sequence 225 
from the human immunodeficiency virus-1 (HIV-1) nucleocapsid protein during SPPS71,73. 226 
These FlAAs have hydration-sensitive dual emission maxima (λem.= 430 nm and 530 nm), 227 
which allowed the interaction between the nucleocapsid protein and nucleic acids to be 228 
monitored to gain insights into the HIV-1 viral life cycle (Figure 4a). Other fluorescent 229 
structures have been explored as solvatochromic amino acids with high sensitivity to their 230 
surrounding microenvironments. For example, phthalimide-based amino acids have been 231 
integrated into peptide structures to study dynamic protein–protein interactions, as in the case 232 
of the PDZ domain88 (Figure 4b), one of the most abundant protein interaction domains in 233 
eukaryotes, or calmodulin89, a major calcium-signal transduction protein. Subsequently, novel 234 
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fluorogenic peptides have been used as conformational reporters of calmodulin activity90,91. In 235 
this case, calmodulin-binding peptides were first identified by in vitro selection using tRNA 236 
carrying an NBD-based amino acid90, which was later replaced with a 4-N,N-dimethylamino-237 
1,8-naphthalimide amino acid that has a similar emission wavelength (λem.= 530 nm) but a 238 
remarkably enhanced fluorogenic behaviour (up to 100-fold fluorescence increase after binding 239 
to calmodulin) 91. Furthermore, a fluorogenic peptide containing the environmentally-sensitive 240 
1,5-naphthyridin-2(1H)-one amino acid has been used to obtain ratiometric fluorescence 241 
measurements at two emission wavelengths (370 nm and 480 nm) in response to 242 
conformational changes in calmodulin61. 243 
[H3] Monitoring peptide-membrane interactions. Fluorogenic peptides can also be designed 244 
to study peptide–membrane interactions, which are crucial for peptide-based therapeutics and 245 
transfection reagents. Cationic peptides, including antimicrobial peptides, are suitable for this 246 
purpose, given their high membrane-binding activity. Fluorogenic analogues of melittin, an 247 
active component of honey bee venom, have been used to study the orientation of melittin in 248 
lipid-rich membranes, revealing details about the varying insertion depths of different residues 249 
(that is, flavone FlAAs) and that melittin is oriented parallel to the surface of cell membranes72. 250 
Similar approaches have been used to study the membrane binding of neuropeptides, which 251 
function as messengers between neurons. Analysis of the fluorescence of two analogues of the 252 
insect neuropeptide helicokinin I (containing the FlAAs β-(4ʹ-hydroxy-ʹ-benzoyl) (ALB; λem.= 253 
360 nm) or 6-dimethyl-amino-2-acyl-naphthalene (ALD; λem.= 530 nm)) interacting with 254 
dodecylphosphatidylcholine micelles was used to develop a model of helicokinin I binding to 255 
membranes92. Furthermore, Fmoc-L-4-cyanotryptophan was incorporated in the membrane-256 
interacting pH-(low) insertion peptide (pHLIP) during SPPS to measure peptide–membrane 257 
binding constants using FRET experiments with the universal membrane stain DiO (ref.31) 258 
(Figure 4c).  259 
[H3] Analytical applications. Fluorogenic peptides have also been used as analytical tools for 260 
the fluorometric detection of specific biomolecules. For example, peptide aptamers containing 261 
an environmentally-sensitive NBD FlAA were evolved in vitro using ribosome display to 262 
identify those that detect verotoxin, a protein that is produced by E. coli and is associated with 263 
haemolytic uraemic syndrome93. Furthermore, a 7-azatryptophan-containing peptide has been 264 
used for detection of haeme levels in cells94 using FRET-based measurements based on the 265 
overlap between the emission spectrum of 7-azatryptophan (λem.= 400 nm) and the absorbance 266 
of the haeme group. Peptides containing other fluorophores have also been used in FRET 267 
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assays to measure protease activity69, including benzoacridone amino acids to detect active 268 
caspase 3 (ref.74), a key enzyme in the apoptotic pathway. 269 
 270 
[H2] Live-cell optical imaging  271 
 272 
 Optical microscopy has allowed researchers to examine the movement of biomolecules 273 
inside the cell with high spatial and temporal resolution. Fluorescent peptides are perfectly 274 
suited for optical imaging, as they can target specific proteins in cells and also contain optical 275 
reporters (that is, FlAAs) that are easily detected using fluorescence microscopes95. To speed 276 
up the detection of pulmonary infections, fluorogenic Trp–BODIPY-containing antimicrobial 277 
peptides were designed for visualization of the deadly fungal pathogen Aspergillus fumigatus 278 
in ex vivo human lung tissue96 (Figure 4d). This residue is an optimal reporter as it retains the 279 
molecular recognition of the native tryptophan and also provides a fluorogenic readout on 280 
specific binding to fungal cells. Other fluorogenic antimicrobial peptides have enabled in situ 281 
detection of bacteria in explanted whole human lungs using real-time optical 282 
endomicroscopy97. The versatility of Trp-BODIPY has led to the preparation of peptide 283 
imaging agents for additional targets. For example, a fluorogenic cyclic peptide that mimics 284 
milk fat globule EGF factor 8 (MFGE8; also known as lactadherin), a protein with high binding 285 
affinity for phosphatidylserine, has been used to image the release of apoptotic bodies into the 286 
extracellular space during programmed cell death98. A red analogue, Trp–redBODIPY, has 287 
been used to prepare fluorogenic cyclic peptides that bind to keratin 1 (KRT1). These peptides 288 
were synthesized using Pd-catalysed C–H activation during SPPS, a labelling approach that is 289 
less disruptive than conventional lysine derivatization and enabled imaging studies to 290 
understand the interaction between immune cells and cancer cells in aggressive breast cancer 291 
tumours47.  292 
 Imaging studies can be also performed to acquire functional readouts from cells. For 293 
example, a fluorogenic coumarin-based amino acid (λem.= 460 nm), the first phosphotyrosine-294 
mimetic FlAA, was used to report the endogenous phosphatase activity of protein tyrosine 295 
phosphatases in live cells99 (Figure 4e). The wash-free imaging capabilities of fluorogenic 296 
peptides makes them valuable tools for applications where samples must be rapidly analysed 297 
with few processing steps, such as in clinical diagnostics or metabolic engineering. For 298 
example, NBD-aminophenylalanine (NBD-amPhe) has been used as a building block for the 299 
preparation of epithelial cell adhesion molecule (EpCAM)-binding peptides that can detect 300 
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circulating tumour cells in the blood100. Furthermore, fluorogenic peptide aptamers have been 301 
used to image in real time the production of paramylon (a carbohydrate granule similar to 302 
starch) by the microalga Euglena gracilis, thereby opening new opportunities in metabolic 303 
engineering101.  304 
[H1] Fluorescent D-amino acids in bacteria 305 
[H3] Visualizing bacterial cell wall growth 306 
Bacterial cells contain two main types of macromolecules that are assembled from 307 
amino acids — namely, proteins, which consist of L-amino acids, and peptidoglycans, which 308 
contain both L-amino acids and D-amino acids. Peptidoglycans are complex polymers that form 309 
the cell wall of bacteria and coordinate multiple important processes, including cell growth and 310 
division102. Their biological importance has made peptidoglycans the target of many 311 
antibiotics, and peptidoglycan biosynthesis has become an area of extensive research for the 312 
discovery of new antimicrobial drugs103. The discovery of fluorescent D-amino acids (FDAAs) 313 
has provided researchers in this field with non-invasive probes to visualize key steps during 314 
the peptidoglycan biosynthesis in bacterial cells104,105.  315 
 Taking advantage of the inherent promiscuity of taxonomically-diverse bacterial to 316 
incorporate D-amino acids as peptidoglycan metabolites106-108, modified D-amino acids have 317 
been used to specifically label sites of new cell wall growth in real time109,110. Structurally-318 
diverse FDAAs, including different reporters of varying size and optical properties, have been 319 
synthesised111 (Figure 5a). For example, ethynyl-D-alanine (EDA), azido-D-alanine (ADA) 320 
and dipeptides, such as ethynyl-D-alanyl-D-alanine (EDA-DA), have been used to label 321 
peptidoglycans in different species of bacteria by cycloadditions with fluorophores. These 322 
bioorthogonal approaches require two reaction steps that can compromise cell viability; 323 
however, these ’clickable’ D-amino acidsare small and thus are minimally disruptive and 324 
generally compatible with multiple reporters. For example, the small size and biological 325 
stability of AlexaFluor 488-conjugated EDA-DA enabled the demonstration that 326 
peptidoglycans are present in the cell wall of the human pathogen Chlamydia trachomatis111. 327 
Alternatively, FDAAs have been employed for single-step labelling of peptidoglycans during 328 
their biosynthesis in bacterial cells, for example, by the metabolic incorporation of FDAAs into 329 
new peptidoglycans to label bacteria with minimal perturbation of the cells and simpler 330 
protocols (that is, fewer washing steps). The good selectivity for bacteria and straightforward 331 
application of FDAAs has opened multiple research avenues in different biological 332 
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applications, ranging from in vivo analysis of the gut microbiota in mice112 and in human fecal 333 
samples113 to light-induced strategies for killing pathogenic bacteria114. 334 
[H3] Multi-colour and multiplexed imaging  335 
 The simple, modular design of FDAAs and their convenient synthesis by condensation 336 
of standard fluorophores to D-amino acids (such as D-lysine and D-diaminopropionic acid), has 337 
not only facilitated their diversification with a broad range of fluorophores but has also enabled 338 
imaging experiments to answer questions about bacterial growth and division with high spatial 339 
resolution. For example, live-cell imaging experiments in which three differently-coloured 340 
FDAAs, NBD-3-amino-D-alanine (NADA; λem = 538 nm), tetramethylrhodamine-D-lysine 341 
(TDL; λem = 565 nm) and 7-hydroxycoumarin-D-alanine (HADA; λem = 450 nm), were time-342 
pulsed to record the chronological steps of cell wall growth in Streptomyces venezuelae (Figure 343 
5b). This approach has also been used to monitor the production of peptidoglycans in single 344 
bacterial cells in different environments, (such as during antibiotic treatment115 or 345 
transplantation109, and to track dynamic interactions between different bacterial species. In a 346 
notable example of the latter, the predation cycle of Bdellovibrio bacteriovorus (a small 347 
bacterial species that preys on larger bacteria) and its prey E. coli was studied by super-348 
resolution imaging of the multiplexed FDAAs HADA, BODIPY-3-amino-D-alanine (BADA; 349 
λem = 512 nm) and tetramethylrhodamine-3-amino-D-alanine (TADA; λem = 565 nm)116.  350 
 Numerous studies have investigated the mechanism by which small and large FDAAs 351 
can be incorporated into peptidoglycans of multiple bacterial species. Most FDAAs behave as 352 
substrate analogues of solvent-accessible, periplasmic peptidoglycan transpeptidases, which 353 
are responsible for the assembly of the cell wall material during growth and division117,118. For 354 
example, HADA was used as an activity-based probe of peptidoglycan transpeptidases to 355 
monitor the spatial distribution of new cell wall versus old cell wall in live Bacillus subtilis117. 356 
Owing to their multiplexing capabilities, FDAAs can also be combined with fluorescently-357 
tagged peptidoglycan biosynthetic proteins for multi-colour imaging studies. For example, 358 
metabolic incorporation of HADA was combined with the localization of key proteins in cell 359 
division (for example, FtsZ) in evolutionarily distinct rod-shaped bacterial species (such as B. 360 
subtilis119 and E. coli120), and MreB was colocalized with an EDA-DA-labelled peptidoglycan 361 
ring during cell division in Chlamydia trachomatis121. Of note, these studies support a new 362 
paradigm in which bacterial division progresses directionally around the cell, in contrast to the 363 
previously described model of uniform cell division. 364 
[H3] Tools for high-throughput screenings 365 
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 However, macromolecular labelling of peptidoglycan structures with conventional 366 
FDAAs has constraints on temporal resolution due to the washing steps that are needed to 367 
reduce the background fluorescence from unincorporated free amino acids. These technical 368 
limitations prompted the design of a series of FDAAs that are non-fluorescent in low viscosity 369 
environments (that is, when the FDAA is moving freely in aqueous media) and fluoresce 370 
strongly when their intramolecular conformation is constrained (for example, after 371 
incorporation into peptidoglycans)122 (Figure 5c). These so-called rotor-FDAAs (RfDAAs) 372 
consist of an electron-donating tetrahydroquinoline core structure coupled to electron-373 
withdrawing carboxy-2-cyanovinyl groups to create efficient push–pull systems (Figure 3c). 374 
The resulting water-soluble amino acids Rf420DL (λem = 420 nm), Rf470DL (λem = 470 nm) 375 
and Rf490DL (λem = 490 nm) have enabled wash-free and real-time imaging of peptidoglycan 376 
biosynthesis, making possible the first high-throughput in vitro assay to probe the activity of 377 
peptidoglycan transpeptidases. The imaging capabilities of these FDAAs will facilitate their 378 
application in biological studies in which monitoring biological events in real time is of 379 
extreme importance, including morphogenesis and drug screening studies. 380 
 381 
[H1] Genetically-encoded FlAAs 382 
[H3] Encoding FlAAs into proteins 383 
 Proteins can be endowed with fluorescence properties by numerous methods, including 384 
by enzymatic and chemical site-specific labelling with optical reporters and by in vitro 385 
translation of proteins with fluorescent tags123-127. These methods have undoubtedly aided the 386 
study of complex biological processes but they do suffer from some limitations, including 387 
potential off-target fluorescence and restriction to in vitro assays. Bearing this in mind, the 388 
genetic encoding of FlAAs has rapidly evolved to enable the generation of artificial proteins 389 
that might overcome some of these challenges128. 390 
Site-specific incorporation of non-natural amino acids by genetic encoding in cells is generally 391 
achieved by assigning an amber stop codon to the non-natural amino acid and supplying the 392 
cells with an exogenous aminoacyl-tRNA synthetase (aaRS) and its corresponding transfer 393 
ribonucleic acid (tRNA). Importantly, the exogenous aaRS and tRNA must be orthogonal and 394 
not cross react with the endogenous aaRSs and tRNAs of the host cell. Then, the orthogonal 395 
aaRS specifically couples the orthogonal tRNA to the non-natural amino acid so that the 396 
‘charged’ tRNA is used by the ribosome for site-specific incorporation of the non-natural 397 
amino acid (Figure 6a). Rapid advances in this technology have led to the efficient synthesis 398 
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of artificial proteins containing non-natural amino acids in live cells and animals129-131. To date, 399 
more than 150 non-natural amino acids, including bioorthogonal, photoreactive and 400 
photocaged amino acids, as well as amino acids with electron paramagnetic resonance (EPR), 401 
infrared (IR) and nuclear magnetic resonance (NMR) labels, have been genetically encoded in 402 
different organisms132. The development of organisms with synthetic genomes133 and the 403 
evolution of quadruplet-codon-decoding ribosomes134,135 will expand the applicability of new 404 
genetically-encoded FlAAs with different chemical structures and/or additional photophysical 405 
properties to label proteins.  406 
[H3] Genetically-encoded FIAAs in prokaryotes 407 
 The FlAAs that have been genetically incorporated into proteins (Figure 6b) can be 408 
broadly classified by whether they are expressed in prokaryotic or in eukaryotic cells. 409 
Following the discovery and application of L-(7-hydroxycoumarin-4-yl)ethylglycine (CouA; 410 
λem.= 380 nm in neutral form; λem.= 450 nm in anionic form), acridon-2-ylalanine (Acd; λem.= 411 
446 nm) and 4-biphenyl-l-phenylalanine (terphenylA; λem.= 342 nm) were developed as 412 
additional FlAAs for site-specific incorporation into proteins in E. coli20,45,136. In these cases, 413 
evolved mutant tyrosyl-aaRSs from the archaeon Methanococcus jannaschii (MjTyrRS) were 414 
used to generate ‘charged’ tRNAs inside the cell, which resulted in successful ribosomal 415 
incorporation. Of note, the MjTyrRS–MjtRNA pair is orthogonal in prokaryotes and has been 416 
evolved for incorporation of several other non-natural amino acids. 417 
CouA is synthesized by incorporating a β-keto ester in the amino acid side chain and then 418 
reacting it with resorcinol by Pechmann condensation20. The ease of synthesis and efficient 419 
incorporation of CouA into proteins has facilitated the widespread application of CouA in 420 
biological studies. As the emission spectrum of CouA overlaps with the excitation spectrum of 421 
cyan fluorescent protein (CFP), CouA was used to engineer a new CFP with a long Stokes shift 422 
of ~110 nm (ref.137). In this case, the precise incorporation of CouA at 20 Å from the CFP 423 
fluorophore results in efficient FRET so that CFP fluorescence (at 426 nm) is detected when 424 
CouA is excited (at 365 nm) (Figure 6c). Furthermore, the sensitivity of CouA to pH and 425 
polarity changes has also been exploited to produce artificial proteins with readouts that are 426 
sensitive to environmental conditions138. For example, this approach was used to investigate 427 
the difference in substrate specificity between the haloalkane dehalogenases DhaA and 428 
DbjA139. Steady-state and time-resolved fluorescence measurements of dehalogenase mutants 429 
containing CouA at specific sites revealed greater hydration in DbjA than in DhaA, which 430 
correlates with the substrate specificity of the two proteins. CouA has also been genetically 431 
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encoded into the transient receptor potential cation channel subfamily V member 1 (TRPV1) 432 
to study the dynamics of receptor activation, with changes in the fluorescence being correlated 433 
with the opening and closing of the channel on binding of capsaicin140.  434 
[H3] Genetically-encoded FIAAs in eukaryotes 435 
Lysine derivatives of 7-hydroxycoumarin (Lys-Cou) have been genetically encoded 436 
into proteins using evolved mutants of Methanosarcina barkeri pyrrolysyl RS (PylRS)–437 
tRNACUA141. The PylRS–tRNA pair142,143 has become an extremely useful tool for genetic 438 
encoding of non-natural amino acids because it is orthogonal to prokaryotes and eukaryotes 439 
and therefore can be used in cells of evolutionarily diverse origins, including E. coli, 440 
Saccharomyces cerevisiae, mammalian cells and even whole intact organisms, such as the 441 
nematode worm Caenorhabditis elegans and the fruit fly Drosophila melanogaster144. ACD 442 
has also been encoded in fluorescent proteins for expression in prokaryotes. The high quantum 443 
yield (~95%, compared with 63% for CouA), efficient synthesis and high photostability of 444 
ACD are some of its key advantages.  445 
 Among the FlAAs that have been genetically encoded in eukaryotes, the most notable 446 
are dansyl and prodan derivatives, such as dansylalanine (λem.= 540 nm) and ANAP (λem.= 490 447 
nm)145-147 (Figure 6b). These FlAAs have been incorporated into proteins expressed in S. 448 
cerevisiae using evolved mutants of the E. coli-derived leucyl-RS–leucyl-tRNACUA pair, which 449 
is orthogonal to those found in eukaryotic cells. A remarkable feature of these amino acids is 450 
that their emission maximum and quantum yield can vary drastically depending on the polarity 451 
of the medium; for example, the quantum yield of dansyl-based amino acids vary from 50% 452 
(λem.= 510 nm) in ethyl acetate to <10% (λem.= 578 nm) in water148; the emission maxima for 453 
ANAP are 490 nm in water and 420 nm in ethyl acetate. This sensitivity to the dielectric 454 
constant of the surrounding environment has been exploited to investigate the dynamics of 455 
different protein structures. For example, ANAP was used to map the regions of the voltage-456 
gated potassium ion channel ion channel that are inaccessible to chemical labelling149 (Figure 457 
6d). First, the FlAA was genetically encoded into different positions in the ion channel 458 
sequence, either the extracellular and intracellular regions, and then electrophysiology and 459 
fluorescence measurements were performed concurrently to identify the regions of the protein 460 
that cooperatively lead to opening of the channel. Similarly, ANAP has been also used to 461 
examine the catalytic activity of a voltage-sensing phosphatase150 and to gain insights into 462 
protein–protein interactions using FRET measurements, as in the case of the pro-apoptotic 463 
protein BAX and the anti-apoptotic protein HSP70 (ref.151). Different mutants of BAX with 464 
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ANAP encoded at three different positions in the protein were tested for binding to HSP70 465 
fused to yellow fluorescent protein (YFP), so that FRET signals were detected only when the 466 
two proteins were in close proximity. This FRET signal was used as a reporter of the interaction 467 
between BAX and HSP70 and helped to discern the mechanism of small molecule-induced 468 
inhibition of this interaction. These examples highlight how genetically-encoded FlAAs can be 469 
used to gain insights into protein dynamics and folding, as well as the interactions between 470 
proteins and other biomolecules. 471 
 472 
[H1] Conclusions and outlook 473 
 Advances in the chemical derivatization of heterocyclic building blocks and 474 
fluorophores have accelerated the design and synthesis of FlAAs with improved properties for 475 
chemical biology studies. To date, the unique reactivity of the indole moiety152,153 has resulted 476 
in the synthesis of multiple tryptophan analogues by different transformations (such as Pd-477 
catalysed couplings and C–H activation). Site-specific modification of other amino acids, 478 
including, amongst others, histidine154,155, phenylalanine49 and tyrosine156,157, will help to 479 
enable other residues with complementary functionalities to be fluorescently labelled and, 480 
ultimately, lead to broader chemical diversity. Similarly, the emergence of new chemistry in 481 
the field of synthetic fluorophores will enable the construction of FlAAs with additional 482 
properties. These properties include not only physicochemical properties, such as small 483 
size158,159 to reduce the effect of labelling in peptides and proteins, but also optical features for 484 
spectroscopy and imaging experiments, including near-infrared emission160,161, super-485 
resolution capabilities162,163, photoactivatable behaviour164,165 or suitability for multimodal 486 
imaging (for example, optoacoustics and positron emission tomography)166,167. A greater 487 
number and variety of FlAAs will create avenues to identify new roles for peptides and proteins 488 
in biological systems. FlAAs with longer emission wavelengths will improve the penetration 489 
depth that is required for in vivo imaging studies, and photoswitching FlAAs may allow 490 
researchers to image the localization and trafficking of proteins using super-resolution 491 
microscopy. New FlAAs might also find important applications in other areas of chemistry in 492 
which they may have been underexplored to date, such as the material sciences, where 493 
fluorescent building blocks embedded in supramolecular structures could provide dynamic 494 
readouts to characterize the formation and properties of new materials in real time, including 495 
nanofibres and peptide hydrogels168,169.  496 
 For biological applications, the design of new methodologies in synthetic biology will 497 
facilitate the integration of new modular blocks into different macromolecular structures. An 498 
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area that will benefit substantially from these developments is genetically-encoded FlAAs. 499 
Although currently available genetically-encoded FIAAs hold huge potential for studying the 500 
dynamics, folding and biomolecular interactions of proteins, their number and types are 501 
limited. Most fluorophores absorb at very short wavelengths that require high energy 502 
excitation and lead to limited tissue penetration and poor signal-to-background ratios, [which 503 
precludes their use in whole organisms. Non-natural amino acids showing good spectral 504 
overlap with existing fluorophores or fluorescent proteins would be also extremely useful to 505 
build FRET pairs within proteins and thereby study dynamic conformational changes with 506 
increased resolution. The UV excitation wavelengths of current FlAAs also reduce their 507 
compatibility with photocaging groups, which are typically cleaved when illuminated at those 508 
wavelengths (for example, 365 nm) 170,171. Therefore, synthetic routes that are able to red-509 
shift the excitation and emission wavelengths172 of non-natural FlAAs would have a 510 
remarkable impact on the design of new artificial proteins. However, this synthetic effort will 511 
need to be matched with advances in the biological counterpart, where the identification of 512 
new aaRS–tRNA pairs that can recognize and incorporate such molecules will be essential 513 
for the successful encoding of novel FlAAs into protein structures. 514 
 515 
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 978 
Figure legends 979 
Figure 1. Applications of FlAAs in chemical biology. The design and synthesis of new 980 
fluorescent amino acids (FlAAs) has created multiple opportunities for in vitro biomolecular 981 
recognition assays (part a), solid-phase peptide synthesis (SPPS) of fluorescent peptides for 982 
optical imaging (part b), genetic encoding of fluorescent building blocks into proteins (part c) 983 
and microbiology experiments to study bacterial growth (part d). Images in part b reproduced 984 
with permission from ref. 96, Springer Nature Limited. Image in part d reproduced with 985 
permission from ref. 112, Springer Nature Limited. 986 
Figure 2. Representative non-natural FlAAs developed in the past decade. Chemical 987 
structures and basic spectral properties of fluorescent analogues of tryptophan (part a) and 988 
fluorescent amino acids (FlAAs) obtained by appending fluorophores to amino acids using a 989 
broad range of chemical reactions (part b). φF, fluorescence quantum yield; Pd, palladium; Rh, 990 
rhodium; CuAAC, copper-catalysed azide–alkyne cycloaddition. 991 
Figure 3. Synthetic schemes for the de novo preparation of non-natural FlAAs. a | Design 992 
of flavone-based fluorescent amino acids (FlAAs) building on tyrosine derivatization71-73. b | 993 
Pyrazoloquinazolines derived from L-aspartic acid as one-photon and two-photon 994 
fluorophores78. c | Synthesis of rotor fluorogenic D-amino acids (RfDAAs) for labelling 995 
peptidoglycan structures in bacterial cells122. Boc, tert-butoxycarbonyl; DCM, 996 
dichloromethane; DDQ, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone; DIPEA, N,N-997 
diisopropylethylamine; DMF, N,N-dimethyl formamide; Fmoc-OSu, N-(9-998 
fluorenylmethyloxycarbonyl)succinimide; TFA, trifluoroacetic acid ; THF, tetrahydrofuran; 999 
Trt-Cl, triphenylmethyl chloride; TSTU, N,N,Nʹ,Nʹ-tetramethyl-O-(N-succinimidyl)uronium 1000 
tetrafluoroborate.  1001 
Figure 4. Bioactive fluorescent peptides for structural studies and optical imaging. a | 1002 
Schematic representation of the interaction between the HIV-1 nucleocapsid peptide W37 1003 
(labelled with the flavone-based fluorescent amino acid (FlAA) M3HFaa) and 1004 
oligonucleotides. The graph shows the fluorescence emission spectra of the W37–M3HFaa 1005 
peptide on binding to different nucleic acids. b | Schematic illustration of the binding between 1006 
a fluorescent peptide containing the FlAA 4-DMAP and a PDZ domain. The graph shows the 1007 
fluorescence emission spectra of the 4-DMAP-containing peptide in the unbound state and 1008 
bound to the PDZ domain. c | Illustration of the pH-(low) insertion peptide (pHLIP) containing 1009 
33 
 
4-cyanotryptophan (which acts as a FRET donor, and DiO-stained large unilamellar vesicles 1010 
(LUVs), which act as FRET acceptors, for the study of peptide–membrane interactions. The 1011 
graph depicts the FRET measurements taken at 512 nm with increasing concentrations of 1012 
labelled pHLIP. d | Chemical structure of the Trp-BODIPY-labelled cyclic peptide PAF26 and 1013 
live-cell confocal imaging of Aspergillus fumigatus over time. Scale bar: 2.5 µm. Multi-photon 1014 
fluorescence microscopy images of ex vivo human lung tissue after incubation with RFP-1015 
expressing A. fumigatus (red) and the Trp-BODIPY-labelled PAF26 peptide (green). Second 1016 
harmonic generation images are shown in cyan. Scale bar: 10 µm. Fluorescence lifetime images 1017 
depicting autofluorescent tissue structures (white arrows) and a PAF26-stained A. fumigatus 1018 
hypha (yellow arrows). Scale bar: 20 µm. e | pER peptide containing a self-immobilizing 1019 
coumarin FlAA that mimics phosphotyrosine (pTyr) to report endogenous activity of protein 1020 
tyrosine phosphatases (PTPs). The graph depicts time-dependent fluorescence measurements 1021 
of the pER peptide before and after ultraviolet (UV) irradiation (365 nm) in HeLa cell lysates. 1022 
Fluorescence microscopy images of HeLa cells after incubation with pER  and UV irradiation 1023 
to visualize intracellular PTP activity (green: pER peptide, red: commercial tracker). Part a 1024 
reproduced with permission from ref. 73, American Chemical Society. Part b was reproduced 1025 
with permission from ref. 88, American Chemical Society. Part c reproduced with permission 1026 
from ref. 31, The Royal Society of Chemistry. Part d reproduced with permission from ref. 96, 1027 
Springer Nature Limited. Part e reproduced with permission from ref. 99, The Royal Society 1028 
of Chemistry. 1029 
Figure 5. Fluorescent D-amino acids for studying bacterial growth. a | Peptidoglycans are 1030 
polymers of L- and D-amino acids and sugars, and a major component of bacterial cell walls. 1031 
The peptidoglycan layer is considerably thicker in Gram-positive than in Gram-negative 1032 
bacteria. b | Chemical structures and optical properties of ‘clickable’ and fluorescent D-amino 1033 
acids (FDAAs) used for labelling peptidoglycan structures in Gram-positive and Gram-1034 
negative bacteria. c | Time-lapse multicolour microscopy images of the bacterium Streptomyces 1035 
venezuelae by pulsed-incubation with NBD-3-amino-D-alanine (NADA; green), 1036 
tetramethylrhodamine-D-lysine (TDL; red), and 7-hydroxycoumarin-D-alanine (HADA; blue). 1037 
d | Schematic representation of the fluorescence activation of the rotor FDAA Rf470DL on 1038 
peptidoglycan labelling and fluorescence microscopy images of Bacillus subtilis depicting 1039 
peptidoglycan labelling using Rf470DL (red) or HADA (cyan) before and after washing. Part 1040 
c reproduced with permission from ref. 110, Wiley VCH. Part d reproduced with permission 1041 
from ref. 122, Springer Nature Limited.  1042 
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Figure 6. Genetically encoded site-specific incorporation of FlAAs in live cells. a | Non-1043 
natural amino acids are site-specifically incorporated into proteins by assigning an amber stop 1044 
codon (UAG) to non-natural amino acids and supplying the cells with an exogenous aminoacyl-1045 
tRNA synthetase (aaRS) and its corresponding tRNA, which charges the tRNA with the non-1046 
natural amino acid. b | Chemical structures of genetically-encoded fluorescent amino acids 1047 
(FlAAs) and their optical properties. c | Adjusting the photophysical properties of a fluorescent 1048 
protein. Site-specific incorporation of L-(7-hydroxycoumarin-4-yl)ethylglycine (CouA) at 1049 
position 39 in cyan fluorescent protein (CFP), resulting in efficient FRET between CouA and 1050 
CFP. When CouA (in blue) is excited at 360 nm, emission from the CFP fluorophore (in cyan) 1051 
at 476 nm is observed. d | Mapping ion channel dynamics. 3-(6-acetylnaphthalen-2-ylamino)-1052 
2-aminopropanoic acid (ANAP) is site-specifically incorporated into both extracellular and 1053 
intracellular positions (black circles) in a voltage-gated potassium ion channel. Voltage-1054 
dependent changes in the fluorescence emission of ANAP revealed information about the 1055 
regions of the ion channel that move cooperatively on opening of the channel. Red spheres in 1056 
the structure are potassium ions. Part c adapted with permission from ref. 137, American 1057 
Chemical Society. Part d adapted with permission from ref. 149, National Academy of 1058 
Sciences USA.  1059 
 1060 
ToC blurb 1061 
Fluorescent amino acids are widely used as building blocks for non-perturbative labelling of 1062 
peptides and proteins. This Review covers recent advances in the design and synthesis of 1063 
FlAAs with bespoke optical properties for different applications in biological studies. 1064 
